Two Pfizer Covid vaccine doses give over 95% protection, shows Israel study

Two doses of Pfizer vaccine stops 98% of deaths, study shows

Margaret Keenan, 90, was the first patient in the world to receive the Pfizer jab in December (Picture: Getty)Two doses of the Pfizer vaccine can provide more than 95% protection against infection, severe illness, and death, new data has shown.A single dose of the jab, meanwhile, is associated with 58% protection against infection, 76% against hospital admission, and 77% against death.The findings are based on Israel’s national-level assessment …

Pfizer/BioNTech Covid vaccine confirmed to protect 95% in largest study yet

The largest real-world study yet of the Pfizer/BioNTech vaccine has confirmed that the jab provided more than 95 percent protection against Covid-19.

New study shows importance of second dose of coronavirus vaccine

The second dose of Pfizer/BioNTech’s coronavirus vaccine can reduce the risk of both hospitalisation and death by more than 95% from seven days after vaccination, a nationwide study by Israel’s Ministry of Health and the pharmaceutical giant found.The real-world research found a significant increase in effectiveness from the first dose, which offers 58% protection against infection, 76% against hospitalisation and is 77% effective at preventing …

Two Pfizer doses ‘95% effective against Covid-19 infection, illness, and death’

The findings are based on a national-level assessment of the effectiveness of the vaccine in Israel.

Pfizer-BioNTech vaccine offers over 95 percent protection against COVID-19, says largest real-world study- Technology News, Firstpost

The global use of the Pfizer/BioNTech vaccine is limited by supply issues, high costs, and ultra-cold chain storage requirements.

[Ticker] Israel study: Two Pfizer doses give over 95% protection

Two doses of the Pfizer/BioNTech vaccine have proved more than 95 percent effective against infection, hospitalisation, and death from Covid-19 in Israel, research found, The Guardian writes. One shot of the vaccine was partially effective, offering 58 percent protection against infection, 76 percent against hospitalisation, and 77 percent against death. The authors of the study in the Lancet medical journal say this shows the importance of havi…